Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients

Advances in Chronic Kidney Disease
T Alp Ikizler

Abstract

Cardiovascular disease (CVD) is the major cause of death in end-stage renal disease (ESRD) patients. Uremic malnutrition and chronic inflammation are important comorbid conditions, closely associated with CVD risk in ESRD patients. A pathophysiologic link between uremic malnutrition, chronic inflammation, and atherosclerosis has been proposed in this patient population. Uremic malnutrition can result from chronic inflammation and can accelerate the progression of cardiovascular disease. Chronic inflammation can also directly predispose ESRD patients to a proatherogenic state. Both uremic malnutrition and chronic inflammation are also associated with increased oxidative stress, a condition proposed as a unifying concept of CVD in uremia. Although a single common etiology has not been identified in this complex process, nutritional, anti-inflammatory, and antioxidant interventions can provide potential treatment options to improve the high mortality and morbidity in ESRD patients.

References

Oct 1, 1978·The American Journal of Clinical Nutrition·E HeckingD Müller
Oct 1, 1990·The American Journal of Clinical Nutrition·N CanoL Cynober
May 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E G Lowrie, N L Lew
Jan 1, 1989·Advances in Experimental Medicine and Biology·J Bergström
Apr 1, 1995·Kidney International·J D KoppleD M Bier
Dec 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J D Kopple
Dec 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G M ChertowE G Lowrie
Feb 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R M Hakim, N Levin
Nov 1, 1995·Journal of the American Society of Nephrology : JASN·J Bergström
Aug 1, 1996·Kidney International·T A Ikizler, R M Hakim
Jan 1, 1996·Blood Purification·C A Dinarello, R A Roubenoff
Dec 19, 1996·The New England Journal of Medicine·W E Mitch, A L Goldberg
Dec 1, 1996·Journal of the American Society of Nephrology : JASN·T A IkizlerR M Hakim
Mar 21, 1998·Kidney International·A R QureshiJ Bergström
Jul 2, 1998·Kidney International·P L KimmelJ H Veis
Aug 5, 1998·Kidney International·W F Owen, E G Lowrie
Sep 2, 1998·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·D B CockramR Kunau
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M JonesJ Moran
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J Bergström, B Lindholm
Jan 14, 1999·The New England Journal of Medicine·R Ross
Jan 19, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B R Bistrian
Feb 13, 1999·Kidney International·J ZimmermannC Wanner
Mar 19, 1999·JPEN. Journal of Parenteral and Enteral Nutrition·A K MortelmansR Vanholder
Jun 22, 1999·The New England Journal of Medicine·G D Sloop
Feb 22, 2000·Mineral and Electrolyte Metabolism·A K Mortelmans, R Vanholder
Apr 15, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M J Sarnak, A S Levey
Jul 8, 2000·Kidney International·A K CheungA S Levey
Feb 13, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J D Kopple
Mar 7, 2001·Kidney International·B R DonG A Kaysen
Mar 10, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F LocatelliC Zoccali
Jun 26, 2001·Journal of the American Society of Nephrology : JASN·George A Kaysen
Dec 12, 2001·American Journal of Physiology. Endocrinology and Metabolism·T Alp IkizlerPaul J Flakoll
Jan 12, 2002·Kidney International·Stephen L SeligerCatherine O Stehman-Breen
Jan 23, 2002·Blood Purification·T Alp Ikizler
May 2, 2002·Kidney International. Supplement·Christoph WannerThomas Metzger
May 2, 2002·Kidney International. Supplement·Peter StenvinkelBengt Lindholm
Jun 1, 2002·Journal of the American Society of Nephrology : JASN·Wulf Palinski, Sotirios Tsimikas
Aug 8, 2002·Kidney International·Kayser CaglarT Alp Ikizler
Aug 22, 2002·The Journal of Clinical Investigation·Lara B PupimT Alp Ikizler
Oct 10, 2002·Kidney International·Jonathan HimmelfarbRaymond M Hakim

❮ Previous
Next ❯

Citations

May 1, 2007·Scandinavian Journal of Urology and Nephrology·Przemyslaw RutkowskiBoleslaw Rutkowski
Aug 17, 2006·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Tsutomu Sanaka
Aug 4, 2015·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Paolo FantiShweta Bansal
Sep 10, 2010·Conservation Biology : the Journal of the Society for Conservation Biology·John GowdyLisi Krall
Feb 13, 2016·Nutrition Research and Practice·Mirey Karavetian, Rana Rizk
Nov 28, 2019·Journal of Nephrology·Jiachuan XiongUNKNOWN Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)
Mar 26, 2005·The American Journal of Nursing·Patricia B McCarley, Patricia B Salai
Sep 8, 2019·Clinical Journal of the American Society of Nephrology : CJASN·Sri Lekha Tummalapalli, Carmen A Peralta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.